BNB Plus Corp

BNB Plus Corp (BNBX) News & Events

$0.163

-0.093 (-56.75%)At close

BNBX News

BNBX Events

7/30 07:30

BNB Plus Concludes Asset Management Agreement with Cypress

BNB Plus announced that, in furtherance of its ongoing strategic review, it has reached a mutual agreement with Cypress Management and its affiliates to conclude their advisory and asset management arrangement, transitioning execution of the Company's BNB treasury strategy fully in-house. Clay Shorrock, President and CEO, noted, "Cypress has been a valued, professional partner throughout our relationship, helping us build a disciplined treasury strategy from the ground up and working constructively with us through this transition. Following our shareholder-led financing a little over a month ago, bringing treasury execution fully in-house tightens the alignment between strategy and execution, and we believe marks an important milestone in our strategic process to build long-term shareholder value."

7/13 08:00

BNB Plus Receives Delisting Determination from Nasdaq

BNB Plus has received a delisting determination from the Hearing Panel of the Nasdaq Stock Market as a result of the Company's non-compliance with the minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capital Market. In accordance with applicable Nasdaq rules, the Company intends to request that the Nasdaq Listing and Hearing Review Council review the Delisting Determination in light of the Company's recently closed financing and further developments in connection with the Company's ongoing strategic review process. If the Listing Council elects to review the matter, it may affirm, modify, reverse, or remand the Hearing Panel's decision. The planned request for Listing Council Review will not stay the Delisting Determination, and trading of the Company's common stock on Nasdaq will be suspended at the open of trading on July 14. The Company has secured approval for its common stock to be quoted on the OTCQB Venture Market, a U.S. trading platform operated by OTC Markets Group. The company anticipates its shares will begin trading on the OTCQB under the same symbol, BNBX, beginning at the open of trading on July 14, or as soon as possible thereafter. The Company does not expect the transition to OTC Markets to impact its business operations, and BNBX will continue to operate as a fully reporting public company with the U.S. Securities and Exchange Commission.

5/26 08:20

BNB Plus Secures $4.1M Convertible Preferred Stock Financing Commitments

BNB Plus secured initial commitments for $4.1M of convertible preferred stock financing, with additional commitments anticipated to bring total proceeds to $5M. Proceeds from the Financing will be used to bolster the Company's digital asset treasury and will provide working capital in support of a comprehensive strategic review. With the anticipated proceeds, the Company expects to hold over $16.4M in cash and digital assets, as valued on May 23, 2026. Investors in the Financing include Comstock Multichain Fund, an investment vehicle managed by Silvermine Capital Advisors, and other new and existing digital-asset-native institutional investors that specialize in the monetization of undervalued assets, including Off the Chain, LP. In conjunction with the Financing, the Company will enter into an advisory arrangement with GlobalStake Infrastructure, which will lead the strategic review of the Company's business, assets, and capital structure. GlobalStake currently operates cutting-edge bare metal infrastructure in tier 4 and 5 data centers across the globe. The strategic review will prioritize evaluating two potential primary value creation pathways: Digital Asset and Related Infrastructure Opportunities: The review will propose a path to unlock strategic opportunities in digital asset and AI infrastructure, including institutional yield generation and the intersection of agentic AI with digital asset payment mechanisms. Monetization of LineaRx. The Company's biotech subsidiary, LRx, will undergo a structured assessment to identify potential monetization opportunities, which may include partnerships, licensing arrangements, asset sales, or other transactions designed to realize value for shareholders.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started